MedTrace Logo

Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome

NCT05233917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-11-15

No results posted yet for this study

Summary

The type of cooking oil used is a crucial factor influencing dietary quality. The purpose of this study is to investigate the effects of olive oil and MLCT oil intervention on glucose and lipid homeostasis in patients with MetS.

Conditions

  • Hyperlipidaemia
  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Olive oil use

Olive oil, 25-30g/d by day for 6 month

DIETARY_SUPPLEMENT

MLCT oil use

MLCT oil, 25-30g/d by day for 6 month

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Yu Zhang, PhD · Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-09
Primary Completion
2023-12-09
Completion
2023-12-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05233917 on ClinicalTrials.gov